Ryan Clements

Managing Director, Life Sciences Strategy

Ryan is a Managing Director in KPMG’s Deal Advisory and Strategy group where his team is focused on serving healthcare and life sciences companies throughout the deals life cycle, from growth, to diligence to transaction execution. He has over 15 years of advisory experience focused on the life sciences and healthcare sectors serving a varied client base from Fortune 20 to early stage and pre-commercial market entrants as well as mid-market and leading global financial services companies. Ryan’s expertise is particularly strong in the generic pharmaceutical space, including understanding generic competition, generic breakopen and launch strategy and generic pricing. Ryan’s expertise is also well utilized in understanding wholesale and distribution practices, the economics of wholesale and distribution, supply chain strategy, inventory management and logistics.

Prior to KPMG, Ryan was a Managing Director at Avalere Health, a boutique life sciences and healthcare focused Advisory firm based in Washington DC, well known for government affairs, corporate affairs and both state and federal policy strategy work. Ryan led many of the firms operations including a variety of initiatives to acquire and expertly deploy various data assets into the firm’s advisory offerings. Ryan led many of the firm’s premiere biopharma and life sciences client relationships, with oversight for the work his teams executed related to health economics and advanced analytics, market access and government affairs.

Ryan was a Director and founder of Red Oak Sourcing, a joint venture between CVS Health and Cardinal Health.  Ryan and his team at Red Oak were responsible for managing the generic drug portfolio on behalf of both parent companies, including negotiating dead net cost with generic drug manufacturers, understanding competitive dynamics on generic launches and break opens, developing inventory management strategies, mitigating supply risk and optimizing supply chain strategy, and understanding regulatory, FDA and government affairs dynamics in play for the generics industry

Before his time at Red Oak, Ryan worked for PwC focused on life sciences and medical device clients

Skip to content